www.BillionPhotos.com / Shutterstock.com
The US Court of Appeals for the Federal Circuit has sent a patent dispute between drugs companies Shire and Watson Pharmaceuticals back to a district court, ruling again that the lower court erroneously construed claims related to Lialda (mesalamine).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Shire; Watson; Actavis; Lialda; US Supreme Court; CAFC; US Court of Appeals for the Federal Circuit; US District Court for the District of Florida; ANDA;